Tag results:

lymphoid cells

Selective Delivery of Low-Affinity IL-2 to PD-1+ T Cells Rejuvenates Antitumor Immunity with Reduced Toxicity

[Journal of Clinical Investigation] Investigators observed that anti–PD-1 therapy depends on IL-2 signaling, which raised the possibility that a lack of IL-2 limited anti–PD-1–induced effector T cell expansion.

Elongation Factor-2 Kinase Is a Critical Determinant of the Fate and Antitumor Immunity of CD8+ T Cells

[Science Advances] eEF-2K KO CD8+ T cells were more metabolically active and showed hyperactivation of the Akt-mTOR-S6K pathway.

Aspirin Activates Resolution Pathways to Reprogram T Cell and Macrophage Responses in Colitis-Associated Colorectal Cancer

[Science Advances] The authors demonstrated that aspirin increased concentrations of the immune-regulatory aspirin-triggered (AT) specialized proresolving mediators, including AT-lipoxin A4 and AT-resolvin D1, in colonic tissues during inflammation-associated colorectal cancer.

Nuclear Factor-Kappa B (NF-κB) Inhibition as a Therapeutic Target for Plant Nutraceuticals in Mitigating Inflammatory Lung Diseases

[Chemico-Biological interactions] Scientists discuss the medical value of nutraceuticals briefly and their ability to mitigate various inflammatory lung diseases through targeting inhibition of NF-κB.

The Anthelmintic Drug Niclosamide Induces GSK-β-Mediated β-Catenin Degradation to Potentiate Gemcitabine Activity, Reduce Immune Evasion Ability and Suppress Pancreatic Cancer Progression

[Cell Death & Disease] Niclosamide inhibited proliferation of pancreatic cancer cells, induced apoptosis via the mitochondrial-mediated pathway, and suppressed cell migration and invasion by antagonizing epithelial-to-mesenchymal transition.

Decade-Long Leukemia Remissions with Persistence of CD4+ CAR T Cells

[Nature] CAR T cells remained detectable more than ten years after infusion, with sustained remission in both patients.

Popular